Sigyn Therapeutics, Inc.
SIGY
$2.75
$0.2610.44%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.77% | 19.43% | -4.30% | -1.45% | 0.83% |
| Total Depreciation and Amortization | -27.27% | -35.23% | -23.08% | -46.72% | -31.86% |
| Total Amortization of Deferred Charges | -36.10% | -58.04% | -27.77% | -30.20% | -13.80% |
| Total Other Non-Cash Items | 390.71% | 348.22% | 400.87% | 158.17% | -660.83% |
| Change in Net Operating Assets | -13.91% | 48.72% | 317.89% | 876.77% | 1,519.12% |
| Cash from Operations | 11.83% | 36.93% | 58.40% | 51.25% | 45.37% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 27.90% | -29.03% | -50.29% | -49.57% | -65.02% |
| Total Debt Repaid | -375.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 100.00% | 100.00% |
| Cash from Financing | 18.86% | -37.04% | -53.52% | -50.07% | -64.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.13% | -88.24% | 174.25% | 84.05% | -220.17% |